查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1877394

疫苗管理解决方案市场：按应用、类型、解决方案类型、部署模式、最终用户、疫苗类型、国家/地区划分 - 全球产业分析、市场规模、市场份额及2025-2032年预测

Vaccine Management Solution Market, By Application, By Type, By Solution Type, By Deployment mode, By End-user, By Vaccine Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年疫苗管理解决方案市场规模为 25.7845 亿美元，从 2025 年到 2032 年将以 13.2% 的复合年增长率成长。

疫苗管理解决方案是简化疫苗管理和接种流程的数位化平台。这些解决方案可帮助医疗机构追踪疫苗库存水准、剂量可用性、有效期限和储存条件。它们也帮助州和地方政府安全快速地进行疫苗接种工作。多家公司利用这些解决方案追踪员工的疫苗接种情况。疫苗可预防疾病在全球范围内的日益流行，使得可靠的疫苗管理系统显得格外重要。政府的疫苗接种活动和对数位医疗基础设施的投资正在推动市场成长。然而，严格的疫苗储存和分发法规也给市场参与者带来了挑战。由于基础设施先进且医疗保健支出较高，北美地区的市场渗透率最高。凭藉快速的疫苗研发、不断提升的产能和频繁的监管审批，美国继续在全球疫苗管理解决方案市场占据主导地位。

疫苗管理解决方案市场—市场动态

全球免疫计划的不断发展将促进市场成长

国家和全球免疫规划的快速扩张是疫苗管理解决方案市场的重要驱动力。各国政府和卫生组织正日益转向数位化疫苗管理平台，以确保疫苗的高效分发、即时追踪和公平取得。这些解决方案有助于监控冷链物流、减少浪费并提高疫苗交付系统的透明度。例如，世界卫生组织（世卫组织）估计，到2023年，全球疫苗接种覆盖率将达到84%，届时将有超过44亿人透过各种免疫规划接种至少一剂疫苗。疫苗接种规模的不断扩大增加了对先进数位化管理系统的需求，促使医疗机构和政府投资于自动化、基于云端的疫苗管理解决方案，以优化营运并确保供应的完整性。

疫苗管理解决方案市场区隔分析：

全球疫苗管理解决方案市场按应用程式、类型、解决方案类型、部署模式、最终用户、疫苗类型和地区进行细分。

平台解决方案和单点解决方案是两种主要类型。预计到2025年，平台解决方案将占据显着的市场份额。此细分市场的成长主要归功于主要市场参与者之间为支持新冠疫苗分发而加强的合作。例如，2020年11月，Infosys有限公司与软体开发公司Salesforce合作，基于Salesforce平台开发了疫苗管理云端解决方案，以协助联邦政府分发新冠疫苗。

根据解决方案类型：由于其强大的资料控制能力、灵活的客製化能力以及对机构安全协议的合规性，本地部署仍然是疫苗管理解决方案市场中最受欢迎的模式。医院、政府机构和製药公司经常使用当地部署系统来管理必须遵守严格监管框架的敏感病患和免疫记录。例如，马尔地夫将于2022年10月推出其全国电子免疫登记系统（EIR），该系统基于该国自身的DHIS2基础设施，并在世界卫生组织的支持下运作。透过内部託管该系统，卫生部保留了对资料存取、储存和安全设定的完全控制权。这些案例凸显了为何本地部署解决方案仍然占据主导地位，尤其是在那些优先考虑资料主权或云端基础架构有限的地区。

疫苗管理解决方案市场—地理洞察

预计到2023年，北美将在全球疫苗管理解决方案市场占据相当大的份额。为控制肝炎、结核病、人类乳突病毒（HPV）等多种疾病的传播，疫苗接种活动的需求不断增长，这推动了该地区市场的成长。例如，根据美国国家生物技术资讯中心（NCBI）2023年3月发布的一项研究，2022年美国报告了8,300例结核病病例。此外，疫苗管理解决方案的日益普及，以及对疫苗接种流程和供应链管理的支持，预计也将推动市场扩张。

美国疫苗管理解决方案市场—国家概况

由于疫苗研发的快速进展、产能的提升以及监管审批的频繁，美国在全球疫苗管理解决方案市场持续创造可观的收入。疫苗製剂（尤其是流感疫苗和儿童疫苗）数量的不断增长，使得高效的数位化平台对于库存追踪、分发和冷链监控变得至关重要。例如，2022年6月，CSL Seqirus完成了其美国工厂1.56亿美元的扩建项目，旨在提升其细胞培养流感疫苗的製剂和填充能力。此外，2021年10月，FDA批准了Seqirus的四价流感疫苗（FLUCELVAX QUADRIVALENT）扩大适用年龄范围。这些进展增加了疫苗的产量和分发的复杂性，加速了美国各地对先进疫苗管理解决方案的采用。

疫苗管理解决方案市场—竞争格局：

IBM、甲骨文公司、SAP SE、印孚瑟斯有限公司、微软公司和德勤会计师事务所是疫苗管理解决方案领域的市场领导者。这些企业利用云端运算、区块链和人工智慧驱动的分析技术来提高疫苗的分发、储存和追踪效率。物联网赋能的冷链监控系统和数据驱动的库存管理平台的使用，确保了疫苗供应链的透明度和即时可视性。技术提供者、医疗机构和政府机构之间的策略合作正在影响市场成长动态。随着全球免疫规划的扩展和数位健康基础设施的完善，为了满足日益增长的对高效可靠疫苗管理解决方案的需求，竞争格局的特点是资料安全、可扩展性和互通性方面的创新。

目录

第一章：疫苗管理解决方案市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 疫苗管理解决方案市场概览（按应用领域划分）
    • 疫苗管理解决方案市场概览（按类型划分）
    • 疫苗管理解决方案市场概览（按解决方案类型划分）
    • 疫苗管理解决方案市场概览（按部署模式划分）
    • 疫苗管理解决方案市场按最终用户分類的概览
    • 疫苗管理解决方案市场概览（按疫苗类型划分）
    • 各国疫苗管理解决方案市场概览
    • 疫苗管理解决方案市场概览（按地区划分）
  • 竞争洞察

第三章：疫苗管理解决方案的关键市场趋势

  • 疫苗管理解决方案市场驱动因素
    • 市场驱动因素的影响分析
  • 疫苗管理解决方案市场限制因素
    • 市场限制因素的影响分析
  • 疫苗管理解决方案市场机会
  • 疫苗管理解决方案市场未来趋势

第四章：疫苗管理解决方案产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：疫苗管理解决方案市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：疫苗管理解决方案市场概况

  • 疫苗管理解决方案市占率分析，2024 年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：疫苗管理解决方案市场－按应用领域划分

  • 概述
    • 按应用领域分類的细分市场占有率分析
    • 供应链管理
    • 库存管理
    • 行政和檔案管理
    • 结果监测
    • 组织支持
    • 病人登记及预约
    • 其他的

第八章：疫苗管理解决方案市场－按类型划分

  • 概述
    • 按类型分類的细分市场占有率分析
    • 平台解决方案
    • 一点解决方案

第九章：疫苗管理解决方案市场－按解决方案类型划分

  • 概述
    • 按解决方案类型分類的细分市场份额分析
    • 本地部署
    • 基于云端的
    • 杂交种

第十章：疫苗管理解决方案市场－以部署模式划分

  • 概述
    • 按部署模式分類的细分市场占有率分析
    • SaaS
    • 基础设施即服务 (IaaS)
    • PaaS
    • 自託管

第十一章：疫苗管理解决方案市场－以最终用户划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 政府设施
    • 企业组织
    • 其他的

第十二章：疫苗管理解决方案市场－按疫苗类型划分

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 活疫苗
    • 灭活疫苗
    • 结合疫苗
    • 类毒素疫苗
    • 亚单位疫苗

第十三章：疫苗管理解决方案市场－依地理划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美疫苗管理解决方案主要製造商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（按应用划分）
    • 北美市场规模及预测（按类型划分）
    • 北美市场规模及预测（按解决方案类型划分）
    • 北美市场规模及预测（依部署模式划分）
    • 北美市场规模及预测（依最终用户划分）
    • 北美洲疫苗市场规模及预测
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲疫苗管理解决方案主要製造商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 欧洲市场规模及预测（按类型划分）
    • 欧洲市场规模及预测（按解决方案类型划分）
    • 欧洲市场规模及预测（依部署模式划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 欧洲疫苗市场规模及预测（依疫苗类型划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区疫苗管理解决方案主要製造商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（按类型划分）
    • 亚太市场规模及预测（按解决方案类型划分）
    • 亚太地区市场规模及预测（依部署模式划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 亚太地区疫苗市场规模及预测（依疫苗类型划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗管理解决方案主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按类型划分）
    • 拉丁美洲市场规模及预测（按解决方案类型划分）
    • 拉丁美洲市场规模及预测（按部署模式划分）
    • 拉丁美洲规模及预测（按最终用户划分）
    • 拉丁美洲疫苗市场规模及预测
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲疫苗管理解决方案主要製造商
    • 中东和非洲市场规模及预测（按国家/地区划分）
    • 中东和非洲市场规模及预测（按应用划分）
    • 中东和非洲市场规模及预测（按类型划分）
    • 中东和非洲市场规模及预测（按解决方案类型划分）
    • 中东和非洲市场规模及预测（按部署模式划分）
    • 中东和非洲市场规模及预测（按最终用户划分）
    • 中东和非洲疫苗市场规模及预测（按疫苗类型划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十四章：主要供应商分析－疫苗管理解决方案产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • IBM Corporation
    • Siemens Healthineers
    • Accenture
    • SAP SE
    • Oracle Corporation
    • Infosys Limited
    • SoftClinic
    • Logistimo Technologies
    • OmniSYS
    • VaxCare Digital Health
    • Helix Software
    • Blue Vector
    • Andor Health
    • STChealth
    • eHealth Africa
    • Others

第十五章：360度分析师视角

第十六章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5760

Vaccine Management Solution Market size was valued at US$ 2,578.45 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.

Vaccine management solutions are digital platforms that simplify the process of managing and administering vaccines. Vaccine management solutions help healthcare providers track vaccine inventory levels, dose availability, expiration dates, and storage conditions. These solutions help state and local governments administer vaccinations safely and quickly. Several companies use this solution to track employee vaccinations. The increasing global prevalence of vaccine-preventable diseases requires reliable vaccine management systems. Government vaccination campaigns and digital health infrastructure investments are driving market growth. However, strict vaccine storage and distribution regulations challenge market participants. Market penetration is highest in North America due to advanced infrastructure and higher healthcare spending. Due to rapid vaccine R&D, increased production capacity, and frequent regulatory approvals, the US continues to dominate the global Vaccine Management Solution Market.

Vaccine Management Solution Market- Market Dynamics

Growing Global Immunization Programs to Boost Market Growth

The rapid expansion of national and global immunization programs is a significant driver of the Vaccine Management Solution Market. Governments and health organizations are increasingly turning to digital vaccine management platforms to ensure efficient distribution, real-time tracking, and equitable access to vaccines. These solutions help to monitor cold chain logistics, reduce waste, and improve vaccine delivery system transparency. For instance, the World Health Organization (WHO) estimates that global vaccination coverage will reach 84% by 2023, with over 4.4 billion people receiving at least one vaccine dose through various immunization programs. The growing scale of vaccination initiatives has increased the demand for advanced digital management systems, encouraging healthcare providers and governments to invest in automated, cloud-based vaccine management solutions to optimise operations and ensure supply integrity.

Vaccine Management Solution Market- Segmentation Analysis:

The Global Vaccine Management Solution Market is segmented on the basis of Application, Type, Solution Type, Deployment mode, End-user, Vaccine Type, and Region.

Platform solutions and one-point solutions are the two types. In 2025, the platform solutions segment holds a significant market share. The segment's growth is attributed to increased collaborations among key market players to support the distribution of COVID-19 vaccines. For example, in November 2020, Infosys Limited and Salesforce, a software development company, collaborated to develop a vaccine management cloud solution based on the Salesforce platform to assist the federal government in the distribution of coronavirus vaccines.

Based on Solution type: On-premise deployment remains the most preferred model in the vaccine management solution market due to its strong data control, customization flexibility, and compliance with institutional security protocols. On-premise systems are frequently used by hospitals, government agencies, and pharmaceutical companies to manage sensitive patient and immunization records that must adhere to strict regulatory frameworks. For instance, in October 2022, the Maldives will launch its nationwide Electronic Immunization Registry (EIR), based on the country's own DHIS2 infrastructure and with World Health Organization support. By hosting the system internally, the Ministry of Health retained complete control over data access, storage, and security settings. Such examples highlight why on-premise solutions remain dominant, particularly in regions that prioritize data sovereignty or operate with limited cloud infrastructure.

Vaccine Management Solution Market- Geographical Insights

North America is expected to hold a sizable share of the global vaccine management solutions market in 2023. The increased need for vaccination campaigns to control the spread of various diseases, such as hepatitis, tuberculosis, human papillomavirus (HPV), and others, is driving regional growth. For instance, according to a study published in March 2023 by the National Centre for Biotechnology Information (NCBI), 8,300 tuberculosis cases were reported in the United States in 2022. Furthermore, an increase in the introduction of vaccine management solutions to support the vaccination process and supply chain management is expected to drive market expansion.

United States Vaccine Management Solution Market- Country Insights

The United States continues to generate significant revenue in the global Vaccine Management Solution Market, owing to rapid advances in vaccine R&D, increased production capacity, and frequent regulatory approvals. The increasing volume of vaccine formulations, particularly influenza and pediatric vaccines, necessitates efficient digital platforms for inventory tracking, distribution, and cold-chain monitoring. For instance, in June 2022, CSL Seqirus completed a USD 156 million expansion of its US facility to improve formulation and fill-finish capabilities for its cell-based influenza vaccines. Furthermore, in October 2021, the FDA approved Seqirus' FLUCELVAX QUADRIVALENT for an extended age range. Such developments increase vaccine output and distribution complexity, hastening the adoption of advanced vaccine management solutions throughout the country.

Vaccine Management Solution Market- Competitive Landscape:

IBM, Oracle Corporation, SAP SE, Infosys Limited, Microsoft Corporation, and Deloitte Touche Tohmatsu Limited are among the market leaders in vaccine management solutions. These businesses use cloud computing, blockchain, and AI-powered analytics to improve vaccine distribution, storage, and tracking efficiency. The use of IoT-enabled cold chain monitoring systems and data-driven inventory management platforms ensures transparency and real-time visibility throughout the vaccine supply chain. Strategic collaborations among technology providers, healthcare organizations, and government agencies are influencing market growth dynamics. As global immunization programmes expand and digital health infrastructures improve, the competitive landscape is characterized by innovation in data security, scalability, and interoperability to meet the growing demand for efficient and dependable vaccine management solutions.

Recent Developments:

In May 2024, Novavax and Sanofi entered into a co-exclusive licensing agreement to jointly commercialize a COVID-19 vaccine and collaborate on the development of novel COVID-19 and influenza vaccine combinations.

In April 2023, Pfizer disclosed results from phase 3 trials of its RSV vaccines. The study of adult patients found that the vaccine was 67% more effective in preventing infections with two associated symptoms and 86% effective in cases of severe disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • IBM Corporation
  • Siemens Healthineers
  • Accenture
  • SAP SE
  • Oracle Corporation
  • Infosys Limited
  • SoftClinic
  • Logistimo Technologies
  • OmniSYS
  • VaxCare Digital Health
  • Helix Software
  • Blue Vector
  • Andor Health
  • STChealth
  • eHealth Africa
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Supply Chain Management
  • Inventory Management
  • Administration and Record Management
  • Outcome Monitoring
  • Organizational Support
  • Patient Registration and Scheduling
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Platform Solutions
  • One Point Solutions

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • On-premise
  • Cloud-based
  • Hybrid

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • SaaS
  • IaaS
  • PaaS
  • Self-hosted

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Government Facilities
  • Corporate Organizations
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live vaccines
  • Inactivated vaccines
  • Conjugate vaccines
  • Toxoid vaccines
  • Subunit vaccines

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Management Solution Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Management Solution Market Snippet by Application
    • 2.1.2. Vaccine Management Solution Market Snippet by Type
    • 2.1.3. Vaccine Management Solution Market Snippet by Solution Type
    • 2.1.4. Vaccine Management Solution Market Snippet by Deployment mode
    • 2.1.5. Vaccine Management Solution Market Snippet by End-user
    • 2.1.6. Vaccine Management Solution Market Snippet by Vaccine Type
    • 2.1.7. Vaccine Management Solution Market Snippet by Country
    • 2.1.8. Vaccine Management Solution Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Management Solution Key Market Trends

  • 3.1. Vaccine Management Solution Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Management Solution Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Management Solution Market Opportunities
  • 3.4. Vaccine Management Solution Market Future Trends

4. Vaccine Management Solution Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Management Solution Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Vaccine Management Solution Market Landscape

  • 6.1. Vaccine Management Solution Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Management Solution Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 7.1.2. Supply Chain Management
    • 7.1.3. Inventory Management
    • 7.1.4. Administration and Record Management
    • 7.1.5. Outcome Monitoring
    • 7.1.6. Organizational Support
    • 7.1.7. Patient Registration and Scheduling
    • 7.1.8. Others

8. Vaccine Management Solution Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Platform Solutions
    • 8.1.3. One Point Solutions

9. Vaccine Management Solution Market - By Solution Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
    • 9.1.2. On-premise
    • 9.1.3. Cloud-based
    • 9.1.4. Hybrid

10. Vaccine Management Solution Market - By Deployment mode

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Deployment mode, 2024 & 2032 (%)
    • 10.1.2. SaaS
    • 10.1.3. IaaS
    • 10.1.4. PaaS
    • 10.1.5. Self-hosted

11. Vaccine Management Solution Market - By End-user

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Government Facilities
    • 11.1.4. Corporate Organizations
    • 11.1.5. Others

12. Vaccine Management Solution Market - By Vaccine Type

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 12.1.2. Live vaccines
    • 12.1.3. Inactivated vaccines
    • 12.1.4. Conjugate vaccines
    • 12.1.5. Toxoid vaccines
    • 12.1.6. Subunit vaccines

13. Vaccine Management Solution Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Vaccine Management Solution Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Vaccine Management Solution Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.11. UK
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.11.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.11.5. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.11.6. UK Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.11.7. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.11.8. UK Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.12. France
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.12.5. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.12.6. France Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.12.7. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.12.8. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.13. Italy
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.13.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.13.5. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.13.6. Italy Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.13.7. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.13.8. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.14. Spain
      • 13.3.14.1. Overview
      • 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Spain Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.14.8. Spain Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.15. The Netherlands
      • 13.3.15.1. Overview
      • 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.15.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.15.5. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.15.6. The Netherlands Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.15.7. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.15.8. The Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Overview
      • 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.16.8. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.17. Russia
      • 13.3.17.1. Overview
      • 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Russia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.17.8. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.18. Poland
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Poland Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.19. Rest of Europe
      • 13.3.19.1. Overview
      • 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.19.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.19.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.19.5. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.19.6. Rest of the Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.19.7. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.19.8. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Vaccine Management Solution Key Manufacturers in Asia Pacific
    • 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.4.6. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.4.7. APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.4.8. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.4.9. APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.10. China
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.10.5. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.10.6. China Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.10.7. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.10.8. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.11. India
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.11.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.11.5. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.11.6. India Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.11.7. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.11.8. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.15. Indonesia
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Indonesia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.16. Thailand
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Thailand Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.5. Latin America (LATAM)
    • 13.5.1. Overview
    • 13.5.2. Vaccine Management Solution Key Manufacturers in Latin America
    • 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.5.6. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.5.7. LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.5.8. LATAM Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.5.9. LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Vaccine Management Solution Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Vaccine Management Solution Industry

  • 14.1. Competitive Benchmarking
    • 14.1.1. Competitive Dashboard
    • 14.1.2. Competitive Positioning
  • 14.2. Company Profiles
    • 14.2.1. IBM Corporation
    • 14.2.2. Siemens Healthineers
    • 14.2.3. Accenture
    • 14.2.4. SAP SE
    • 14.2.5. Oracle Corporation
    • 14.2.6. Infosys Limited
    • 14.2.7. SoftClinic
    • 14.2.8. Logistimo Technologies
    • 14.2.9. OmniSYS
    • 14.2.10. VaxCare Digital Health
    • 14.2.11. Helix Software
    • 14.2.12. Blue Vector
    • 14.2.13. Andor Health
    • 14.2.14. STChealth
    • 14.2.15. eHealth Africa
    • 14.2.16. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us